Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs

• Published in: The International journal of drug policy 2021-10, Vol.96, p.103356-103356, Article 103356
• Main Authors: Levander, Ximena A., Vega, Taylor A., Seaman, Andrew, Korthuis, P. Todd, Englander, Honora
• Format: Article
• Language: English
• Subjects: Access; Addictions; Adult; Adults; Candidates; Coordination; Drug abuse; Drug addiction; Drug policy; Drug use; Drugs; Health care access; Health Services Accessibility; Hepatitis; Hepatitis C; Hepatitis C - drug therapy; Hepatitis C virus; Hospital; Hospitalization; Hospitals; Humans; Inpatient care; Intervention; Male; Medical referrals; Medical screening; Medical treatment; Openness; Opioids; Outpatient treatment; Patient admissions; Peers; Perception; Pharmaceutical Preparations; Qualitative; Qualitative research; Substance Abuse, Intravenous; Substance-related disorders; Theoretical framework; Viruses
• ISSN: 0955-3959; 1873-4758
• DOI: 10.1016/j.drugpo.2021.103356

Gaps remain in the hepatitis C virus (HCV) care cascade for people who use drugs (PWUD). Acute medical or surgical illnesses requiring hospitalisation are an opportunity to address addiction, but how inpatient strategies could affect HCV care accessibility for PWUD remains unknown. We explored patient perspectives of hospital-based interventions using an integrated framework of access to HCV care. We conducted a qualitative study of hospitalised adults (n=27) with HCV and addiction admitted to an urban academic medical centre in the United States between June and November 2019. Individual interviews were audio-recorded, transcribed, and dual-coded. We analysed data with coding specific for hospital-based interventions including screening, conducting HCV-related laboratory work-up, starting treatment, connecting with peers, and coordinating outpatient care. We analysed coded data at the semantic level for emergent themes using a framework approach based off an integrated framework of access to HCV care. The majority of participants primarily used opioids (78%), were white (85%) and men (67%). Participants frequently reported HCV screening during previous hospitalisation with rare inpatient connection to HCV-related services. Participants expressed willingness to discuss HCV treatment candidacy during hospitalisation; however, lack of inpatient conversations led to perception that “nothing could be done” during admission. Participants expressed interest in completing inpatient HCV work-up to “get the ball rollin’” – consolidating care would enhance outpatient service permeability by reducing barriers. Others resisted HCV care coordination, preferring to focus on “immediate” issues including health conditions and addiction treatment. Participants also expressed openness to engaging with peers about HCV, noting shared drug use experience as critical to a peer relationship when discussing HCV. Hospitalised PWUD have varied priorities, necessitating adaptable interventions for addressing HCV. Hospitalisation can be an opportunity to address HCV access to care including identification of treatment eligibility, consolidation of care, and facilitation of HCV-related referrals.